Description
**CJC-1295 with DAC Research Overview**
—
**1. What it does**
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the anterior pituitary gland to release more growth hormone (GH) and subsequently increases levels of IGF-1 (Insulin-like Growth Factor 1). The “with DAC” modification significantly extends its half-life, allowing for prolonged stimulation of GH release over several days.
—
**2. What are the main reported benefits**
– Increased growth hormone and IGF-1 levels
– Enhanced muscle growth and lean body mass
– Improved fat metabolism and reduction of body fat
– Enhanced recovery from exercise or injuries
– Improved sleep quality
– Better skin elasticity and anti-aging effects
– Boosted immune system function
—
**3. What are its normal applications**
– Research into growth hormone deficiency treatments
– Anti-aging and regenerative medicine studies
– Studies on muscle wasting disorders
– Athletic performance and recovery research
– Investigations into fat loss and metabolic enhancement
—
**4. What are its common side effects**
Reported side effects for CJC-1295 with DAC include:
– Mild water retention
– Tingling or numbness (especially in hands and feet)
– Injection site irritation
– Headache
– Increased hunger
– Fatigue
Most side effects are mild and often resolve with dosage adjustment.
—
**5. What is the recommended administration or dosage**
– **Typical Dosage**: 1 mg to 2 mg per injection, administered 1 to 2 times per week
– **Administration Route**: Subcutaneous injection
**Timing:**
– Due to its long half-life (~8 days), injections are typically spaced several days apart (e.g., every 3–4 days).
**Preparation:**
– CJC-1295 with DAC is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water prior to administration.
—
